Lacey David L. is a director of Arcus Biosciences Inc.
Person profile
Roles
Address
Brisbane, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Arcus Biosciences, Inc.
16 Jun 23
4
Atreca, Inc.
15 Jun 23
4
Nurix Therapeutics, Inc.
4 May 23
4
Arcus Biosciences, Inc.
16 Jun 22
4
Atreca, Inc.
10 Jun 22
4
Nurix Therapeutics, Inc.
6 May 22
4
Atreca, Inc.
11 Jun 21
4
Arcus Biosciences, Inc.
7 Jun 21
4
Nurix Therapeutics, Inc.
24 May 21
3
Nurix Therapeutics, Inc.
23 Jul 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jun 23 | RCUS Arcus Biosciences | Common Stock | Grant | Acquire A | No | No | 0 | 6,800 | 0.00 | 49,252 |
15 Jun 23 | RCUS Arcus Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 19.6 | 19,500 | 382.20 k | 19,500 |
13 Jun 23 | BCEL Atreca Inc - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.18 | 12,000 | 14.16 k | 12,000 |
4 May 23 | NRIX Nurix Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 9.44 | 25,000 | 236.00 k | 25,000 |